Press Releases
- 05/16/2012 - NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay
- 04/09/2012 - NanoString Technologies Names Joseph M. Beechem Senior Vice President of R&D
- 04/03/2012 - Oxford Finance and Silicon Valley Bank Provide $15 Million Senior Credit Facility to NanoString Technologies
- 03/30/2012 - NanoString Introduces Three New Products at AACR Annual Meeting
- 12/08/2011 - NanoString Technologies Announces Positive Results from First Validation Study of PAM50-based Breast Cancer Assay
- 11/07/2011 - NanoString Secures $20M in Series D Financing
- 10/12/2011 - NanoString Announces Launch of Second Generation nCounter Analysis System
- 09/21/2011 - NanoString Introduces Solution for Simultaneously Measuring miRNA and mRNA Expression Levels
Featured Publications
- Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
Northcott PA, et al., “Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples” Acta Neuropathologica 123(4): 615-26. November 6, 2011
- Access your FFPE archives with confidence - nCounter provides superior performance to PCR
Reis PP, et al., “mRNA transcript quantification in archival samples using multiplexed, color-coded probes.” BMC Biotechnol vol. 108 no. 19 7956-7961. May 9, 2011
- Digital sequencing + digital validation = data you can publish
Sun Z, et al., “Integrated Analysis of Gene Expression, CpG Island Methylation, and Gene Copy Number in Breast Cancer Cells by Deep Sequencing” PLoS ONE Vol 6-2, e17490. February 25, 2011
- Turn discoveries into practical tools for routine analysis
Bock C, et al., “Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines” Cell 144, 439-452. February 4, 2011
NanoString News and Highlights
NEW PRODUCT
nCounter@ Plex2 Assay Multiplex in 2-Dimensions
NEW PRODUCT
nCounter@ Cancer CN Assay
Copy Number Analysis of 86 Cancer Genes